Tumor Ablation Market Size, Share & Trends Report

Tumor Ablation Market Size, Share & Trends Analysis Report By Treatment (Surgical, Percutaneous), By Technology (Cryoablation, IRE, MWA, RFA), By Application (Liver, Lung, Breast, Prostate), And Segment Forecasts, 2019 - 2026

  • Published Date: Mar, 2019
  • Base Year for Estimate: 2018
  • Report ID: 978-1-68038-746-9
  • Format: Electronic (PDF)
  • Historical Data: 2015 - 2017
  • Number of Pages: 119

Industry Insights

The global tumor ablation market size was valued at USD 1.03 billion in 2018 and is expected to grow at CAGR of 11.12% over the forecast period. The increasing prevalence of cancer is the major factor contributing to the market growth. According to the statistics published by the World Health Organization (WHO), nearly 18.1 million cancer cases were newly registered in 2018 and the countries with high human development index have nearly 3 times more cancer cases as compared to low or medium index countries.

This will also boost the market growth over the forecast period. Extensive usage of minimally invasive procedures owing to their benefits, such as speedy recovery, less trauma, and minimal complications, is anticipated to boost the demand for tumor ablation technologies, thereby leading to the growth of the market.

U.S. tumor ablation market

Supportive government initiatives, such as National Cancer Control Programmes (NCCP), which aims at reducing cancer incidence and on improving the quality of care, are anticipated to enable access to affordable and quality care; thereby, facilitating market expansion.

Furthermore, advancements in terms of technology, such as thermal ablation, laser ablation, irreversible electroporation, and High-Intensity Focused Ultrasound (HIFU), and increasing per capita income levels are anticipated to increase the adoption of advanced tumor ablation techniques.

Technology Insights

On the basis of technology, the market has been segmented into microwave, radiofrequency, cryoablation, and other technologies, such as radioiodine, HIFU, laser ablation. The radiofrequency technology held substantial market share in 2017. Prominent application of this technology in solid tumor removal and its specificity contributed to its growth. Moreover, the efficiency of this method is anticipated to fuel the segment growth.

Microwave ablation technology is anticipated to witness remunerative growth over the forecast period owing to benefits offered by this technology, such as larger tumor ablation volume, consistency in high temperature, lesser time, reduced procedural pain, and optimal heating of the cystic mass. Furthermore, minimum procedure time (5-10 minutes), improved efficacy with minimal complications, and reduced hospital stay are expected to drive the growth of this segment.

Treatment Insights

On the basis of treatment, the market has been segmented into surgical procedures, laparoscopic procedures, and percutaneous procedures. Surgical ablation segment held a substantial market share in 2018. Increased prevalence of liver and breast cancer, which require open surgical procedures, contributed to the segment growth.

On the other hand, percutaneous ablation has been anticipated to be the fastest-growing segment. Quick surgery time, faster recovery, and patient comfort are high-impact rendering factors for the growth of this segment. Rising number of minimally invasive surgeries performed is also likely to contribute to the segment growth.

Application Insights

On the basis of application, the market is segmented into liver cancer, breast cancer, lung cancer, prostate cancer, and other cancers. Other segment includes various types of cancers such as bone metastasis, kidney cancer, and ENT cancer. Increasing cases of these cancers and availability of advanced methods are anticipated to facilitate market growth. Liver cancer led the market in 2018 due to the increased cases of bile duct and primary liver cancers. Lung cancer is anticipated to expand at the highest CAGR of 12.6% during the forecast period due to increasing incidence of the disease.

Regional Insights

North America dominated the overall market in 2018 accounting for 34.75% of the global share. Major factors contributing to the region’s growth include high disposable income levels, availability of reimbursement, and increasing prevalence of cancers, especially in U.S. and Canada, and government support for quality healthcare. For instance, in U.S., the Patient Protection and Affordable Care Act (PPACA), promotes quality and affordable health insurance, thereby reducing the overall costs of healthcare. In addition, precision medicine initiative is formulating the tailored strategies on unique characteristics of diseases. Europe accounted for 24.03% of the global share in 2018.

Global tumor ablation market

A greater extent of public funding in Europe’s healthcare system has contributed to this growth. Moreover, growing geriatric population coupled with government support to control cancer is estimated to boost the market growth in this region. For instance, the European Cancer Observatory aims to create awareness about cancer, thus facilitating the market development. Asia Pacific is expected to witness the maximum CAGR over the forecast period owing to improving healthcare infrastructure and supportive government initiatives. Moreover, economic developments in countries, such as India and China, are expected to further fuel the market growth.

Tumor Ablation Market Share Insights

Key companies in the market are Galil Medical, Inc.; Misonix, Inc.; HealthTronics; Boston Scientific Corporation; Medtronic Plc; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical, Inc. Most of them have undertaken various strategies including new product launches, collaborations, technological advancements, and M&A to sustain the competition. For instance, Galil Medical Inc. launched a new family of cryoablation needles, IcePearl 2.1 CX, IceFORCE 2.1CX to strengthen their product portfolio.

Report Scope

Attribute

Details

Base year for estimation

2018

Actual estimates/Historical data

2015 - 2017

Forecast period

2019 - 2026

Market representation

Revenue in USD Million and CAGR from 2019 to 2026

Regional scope

North America, Europe, Asia Pacific, Latin America, & MEA

Country scope

U.S., Canada, Germany, U.K., France, Italy, Spain, China, Japan, India, Thailand, South Korea, Brazil, Mexico, Argentina, Colombia, South Africa, Saudi Arabia, and UAE

Report coverage

Revenue, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analysts working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization


Segments Covered in the Report

This report forecasts revenue and volume growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research, Inc. has segmented the global tumor ablation market report on the basis of technology, treatment, application, and region:

  • Treatment Outlook (Revenue, USD Million, 2015 - 2026)

    • Surgical Ablation

    • Laparoscopic Ablation

    • Percutaneous Ablation

  • Technology Outlook (Revenue, USD Million, 2015 - 2026)

    • Radiofrequency Ablation

    • Cryoablation

    • Microwave Ablation

    • Irreversible Electroporation

    • Other Ablation Technologies

  • Application Outlook (Revenue, USD Million, 2015 - 2026)

    • Liver Cancer

    • Lung Cancer

    • Breast cancer

    • Prostate Cancer

    • Other Cancer

  • Regional Outlook (Revenue, USD Million, 2015 - 2026)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

      • Thailand

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

Key questions answered by the report
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified